Literature DB >> 16513635

Quaternary structure and cleavage specificity of a poxvirus holliday junction resolvase.

Alonzo D Garcia1, Joel Otero, Jacob Lebowitz, Peter Schuck, Bernard Moss.   

Abstract

Recently, poxviruses were found to encode a protein with signature motifs present in the RuvC family of Holliday junction (HJ) resolvases, which have a key role in homologous recombination in bacteria. The vaccinia virus homolog A22 specifically cleaved synthetic HJ DNA in vitro and was required for the in vivo resolution of viral DNA concatemers into unit-length genomes with hairpin telomeres. It was of interest to further characterize a poxvirus resolvase in view of the low sequence similarity with RuvC, the absence of virus-encoded RuvA and RuvB to interact with, and the different functions of the viral and bacterial resolvases. Because purified A22 aggregated severely, studies were carried out with maltose-binding protein fused to A22 as well as to RuvC. Using gel filtration, chemical cross-linking, analytical ultracentrifugation, and light scattering, we demonstrated that A22 and RuvC are homodimers in solution. Furthermore, the dimeric form of the resolvase associated with HJ DNA, presumably facilitating the symmetrical cleavage of such structures. Like RuvC, A22 symmetrically cleaved fixed HJ junctions as well as junctions allowing strand mobility. Unlike RuvC and other members of the family, however, the poxvirus enzyme exhibited little cleavage sequence specificity. Structural and enzymatic similarities of poxvirus, bacterial, and fungal mitochondrial HJ resolvases are consistent with their predicted evolutionary relationship based on sequence analysis. The absence of a homologous resolvase in mammalian cells makes these microbial enzymes excellent potential therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513635     DOI: 10.1074/jbc.M600182200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Poxvirus DNA replication.

Authors:  Bernard Moss
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-09-01       Impact factor: 10.005

2.  Metal cofactors in the structure and activity of the fowlpox resolvase.

Authors:  Matthew J Culyba; Young Hwang; Jimmy Yan Hu; Nana Minkah; Karen E Ocwieja; Frederic D Bushman
Journal:  J Mol Biol       Date:  2010-04-07       Impact factor: 5.469

3.  Structure and Metal Binding Properties of a Poxvirus Resolvase.

Authors:  Huiguang Li; Young Hwang; Kay Perry; Frederic Bushman; Gregory D Van Duyne
Journal:  J Biol Chem       Date:  2016-03-24       Impact factor: 5.157

4.  Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.

Authors:  Steven J Conrad; Jia Liu
Journal:  Methods Mol Biol       Date:  2019

5.  DNA binding and cleavage by the fowlpox virus resolvase.

Authors:  Matthew J Culyba; Young Hwang; Nana Minkah; Frederic D Bushman
Journal:  J Biol Chem       Date:  2008-11-12       Impact factor: 5.157

Review 6.  Orthopoxvirus targets for the development of new antiviral agents.

Authors:  Mark N Prichard; Earl R Kern
Journal:  Antiviral Res       Date:  2012-03-08       Impact factor: 10.103

Review 7.  Cruciform structures are a common DNA feature important for regulating biological processes.

Authors:  Václav Brázda; Rob C Laister; Eva B Jagelská; Cheryl Arrowsmith
Journal:  BMC Mol Biol       Date:  2011-08-05       Impact factor: 2.946

8.  Single bacterial resolvases first exploit, then constrain intrinsic dynamics of the Holliday junction to direct recombination.

Authors:  Sujay Ray; Nibedita Pal; Nils G Walter
Journal:  Nucleic Acids Res       Date:  2021-03-18       Impact factor: 16.971

9.  Potential link of single nucleotide polymorphisms to virulence of vaccine-associated field strains of lumpy skin disease virus in South Africa.

Authors:  Antoinette van Schalkwyk; Pravesh Kara; Karen Ebersohn; Arshad Mather; Cornelius Henry Annandale; Estelle Hildegard Venter; David Brian Wallace
Journal:  Transbound Emerg Dis       Date:  2020-09-02       Impact factor: 4.521

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.